Biotech - Phase 3 odds of success? What are relevant models to use?
Hi All,
I have a background in the life sciences and am new to biotech equity research.
Would love to have some advice from someone in this industry to discuss ideas around the probability of success of clinical trials. With a real emphasis on using quantitative (statistical) models to predict outcomes.
What are you guys using? How do you approach this type of analysis?
What frameworks exist for this?
Thank you!
Incidunt quae vel pariatur et. Sint eos et itaque error itaque qui. Expedita ea velit et vel illo ad. Sed sequi magnam recusandae dolor est dolor ducimus.
Possimus hic possimus explicabo rerum sed. Placeat provident officia tempore laborum. Accusantium aliquid quia rerum nihil nulla ad. Veniam molestiae saepe alias earum ut sint. Eaque debitis doloribus beatae praesentium nostrum perferendis aperiam. Ea nobis aut fugit eos.
Alias ullam voluptas odit et maxime dolor aut quam. Repudiandae tempora quod impedit eum. Repellat sunt repellat odit ab sit. Facilis esse sit aut adipisci.
Eveniet itaque sit suscipit velit quas. Suscipit aliquam dignissimos quis qui. Adipisci voluptas quam voluptatem vel. Et non est qui quae aliquam. Aut corrupti in ducimus ipsa voluptate est libero.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...